Clinical Trials Logo

Filter by:
NCT ID: NCT02387853 Completed - Psoriasis Vulgaris Clinical Trials

Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

Start date: March 2016
Phase: Phase 2
Study type: Interventional

An international, multi-centre, prospective, open-label, non-controlled, single-group, 4-week trial in adolescent subjects with plaque psoriasis.

NCT ID: NCT02387151 Completed - Rejection Clinical Trials

Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients

Neptune
Start date: March 2015
Phase: Phase 1
Study type: Interventional

This study will test whether selected allogeneic bone marrow derived MSCs are safe by assessing the composite end point Biopsy Proven Acute Rejection (BPAR)/ graft loss at 12 months.

NCT ID: NCT02386839 Completed - Clinical trials for Retinopathy of Prematurity (ROP)

Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)

PEDAL
Start date: March 26, 2015
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the long-term efficacy and safety outcomes following short-term exposure to rhIGF-1/rhIGFBP-3 versus standard neonatal care in Study ROPP-2008-01 (NCT01096784).

NCT ID: NCT02386345 Completed - Atrial Fibrillation Clinical Trials

Topera E-FIRM Registry

Start date: March 2015
Phase:
Study type: Observational

This is a registry to assess the safety and effectiveness of FIRM guided procedures for the treatment of symptomatic any type of atrial fibrillation. FIRM (Focal Impulse and Rotor Modulation) guided ablation is defined as ablating rotors identified by the FIRMap® basket catheter for visualising of rotors with the RhythmView® mapping system. In addition to the FIRM guided ablation any other ablation method could be applied.The acute success of FIRM ablations is defined as elimination of rotors defined by absence of rotors. Data items will be collected, if available, consistent and applicable with routine and standard clinical care at each participating site.

NCT ID: NCT02385344 Completed - Clinical trials for Coronary Artery Bypass

Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery

REQUEST
Start date: April 2015
Phase:
Study type: Observational [Patient Registry]

The purpose of the registry is to collect information regarding the number and type of coronary artery bypass (CAB) surgical procedure changes that are made based on intraoperative guidance information using transit time flow measurements (TTFM) and ultrasound image capabilities provided with the Medistim device.

NCT ID: NCT02385279 Completed - Coronary Stenosis Clinical Trials

Study Comparing the MiStent SES Versus the XIENCE EES Stent

DESSOLVE III
Start date: March 20, 2015
Phase: N/A
Study type: Interventional

The primary objective of this study is to compare the performance of MISTENT to that of XIENCE in an all-comers patient population with symptomatic ischemic heart disease. The patients will be followed through 3 years for major clinical events.

NCT ID: NCT02385188 Completed - Clinical trials for Paget Disease, Extramammary

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

Start date: May 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety and immunological response of topical 5% imiquimod cream for non-invasive vulvar Paget's disease.

NCT ID: NCT02385149 Completed - Healthy Clinical Trials

Improving Resilience With Whole Grain Wheat

Graandioos
Start date: January 2015
Phase: N/A
Study type: Interventional

This study investigates the health benefits of whole grain wheat on cardiovascular/ cardio-metabolic health, including glucose metabolism, by means of applying a mixed meal challenge. This study also investigates the health benefits of whole grain wheat (WGW) on liver- and adipose tissue health and evaluates the potential of do-it-yourself (DIY) devices in quantifying health effects in a nutritional intervention study.

NCT ID: NCT02384538 Completed - Hand Osteoarthritis Clinical Trials

A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

Start date: July 2013
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled study to compare the safety and efficacy of ABT-981 to placebo in subjects with erosive hand osteoarthritis.

NCT ID: NCT02384460 Completed - Clinical trials for Epidermolysis Bullosa

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Start date: March 11, 2015
Phase: Phase 3
Study type: Interventional

The aim was to assess the efficacy and safety of SD-101-6.0 cream versus Placebo (SD-101-0.0) cream in the treatment of skin lesions in participants with Epidermolysis Bullosa. Funding Source - United States Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD).